The Limited Times

Now you can see non-English news...

New crown pneumonia | Oxford vaccine has unknown side effects and stops Xu Deyi refers to a two-pronged procurement plan

2020-09-10T10:46:46.855Z

The University of Oxford and AstraZeneca in the United Kingdom have encountered a blockade in the development of a new coronary pneumonia vaccine. The research team found that the vaccine had serious adverse side effects, and the experiment was temporarily suspended. When asked about the purchase of vaccines by the Hong Kong government, Deputy Director of the Food and Health Bureau Xu Deyi described this as a necessary process for drug research and will adopt a two-pronged approach to procurement, including submitting a letter of intent to participate in the global acquisition mechanism for the new crown vaccine (COVAX mechanism), but was eventually distributed The number has not been finalized; it is also reiterated that the preparations for the temporary hospital are still active in response to the fourth wave of the epidemic.



Social News

Written by: Lao Minyi

2020-09-10 18:35

Last update date: 2020-09-10 18:35

The University of Oxford and AstraZeneca in the United Kingdom have encountered a blockade in the development of a new coronary pneumonia vaccine. The research team found that the vaccine had serious adverse side effects, and the experiment was temporarily suspended.

When asked about the purchase of vaccines by the Hong Kong government, Deputy Director of the Food and Health Bureau Xu Deyi described this as a necessary process for drug research and will adopt a two-pronged approach to procurement, including submitting a letter of intent to participate in the global acquisition mechanism for the new crown vaccine (COVAX mechanism), but was eventually distributed The number has not been finalized; it is also reiterated that the preparations for the temporary hospital are still active in response to the fourth wave of the epidemic.

▼List of reopening and continued restrictions starting on September 11▼

+19

+19

+19

Xu Deyi said today (10th) that it is now in the process of rigorous drug research. Before the drug enters the market and is used in large quantities, the side-effect performance of the drug is checked. Once suspected side-effects are found, a third-party expert is required to review and review the vaccine. It is directly related.

Xu said that before purchasing vaccines, the Hong Kong government will adopt a two-pronged approach, including through the COVAX mechanism, to assist different manufacturers in the research and development, manufacture and distribution of vaccines in different countries in a timely, efficient and massive amount of support. A letter of intent has been submitted on Japan, the COVAX mechanism also hopes to provide each participating country with a quota of about 20% of the population, but the final distribution depends on how many countries participate and funds.

As for the second method, he said that he has already negotiated with individual R&D and manufacturing pharmaceutical companies, but there are confidentiality requirements and it is inconvenient to disclose details. The Science Committee of the Department of Health will review, analyze and provide recommendations for the government.

The temporary hospital is actively preparing

Xu Deyi also said that foreign and local experts continue to remind that the new crown pneumonia epidemic is still breaking out in various places and it takes a long time to be controlled. In addition, effective vaccines have not been officially produced and used in large quantities. , And the third wave of hundreds of confirmed cases in the past few days has happened to him the most worried thing.

He emphasized that the government is not slack, and preparations for the temporary hospital are actively being carried out in response to the fourth wave of the epidemic.

Xu Deyi pointed out that in order to respond to the fourth wave of the epidemic, preparations for the temporary hospital are actively proceeding.

(Photo by Yu Junliang)

New Coronary Pneumonia | Oxford Vaccine Test Has Side Effects Yuan Guoyong: Not rare, but research should be careful

New Coronary Pneumonia | The University of Hong Kong and the Mainland developed a nasal spray vaccine approved for clinical trials

[New Crown Vaccine] Suspected side effects of UK product candidates include global suspension of clinical trials in Japan and the United States

Participants in clinical trials suspected of serious adverse reactions AstraZeneca suspends Oxford vaccine testing

▼Resumption Guidelines▼

+4

+4

+4

▼Citizens and officials' participation in the National Testing Program ▼

+11

+11

+11

New crown pneumonia vaccine

Source: hk1

All news articles on 2020-09-10

You may like

Trends 24h

Latest

© Communities 2019 - Privacy